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INTRODUCTION 
 
The urinary tract is the most common site of nosocomial infection. 
Most of these infections follow instrumentation of the urinary tract, mainly 
urinary catheterization and are also a major source of resistant nosocomial 
pathogens. Catheter-associated urinary tract infection (CAUTI) is the most 
common nosocomial infection in hospitals and nursing homes, comprising 
>40% of all institutionally acquired infections (Kunin, 1997). Nosocomial 
bacteriuria or candiduria develops in up to 25% of patients requiring a 
urinary catheter for > 7 days, with a daily risk of 5%. Although not all 
catheter-associated urinary tract infections can be prevented, it is believed 
that a large number could be avoided by the proper management of the 
indwelling catheter. 
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AIM OF THE STUDY 
 
The aim of the study is to analyze the incidence, clinical symptoms, 
microbiological flora, sensitivity of organisms of urinary tract infection in 
bladder catheterized patients and the influence of the days of catheterization 
in catheter associated urinary tract infection. 
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REVIEW OF LITERATURE 
Definitions 
Bacteriuria:  
Bacteria are found in the urine, irrespective if there are symptoms of 
urinary tract infection or not. 
Asymptomatic bacteriuria: 
 Significant bacteriuria (more than 108 bacteria/L) without symptoms. 
Urinary tract infection:  
An infection localized somewhere in the urinary tract. May include 
asymptomatic bacteriuria but mostly only symptomatic infections. 
Symptomatic urinary tract infection: 
 Presence of symptoms caused by the urinary tract infection, as 
opposed to asymptomatic bacteriuria. 
Cystitis: 
Inflammatory syndrome and infection of the bladder with signs and 
symptoms of dysuria, frequency, urgency, and suprapubic tenderness. 
Pyelonephritis: 
 Bacterial infection of the kidney (renal parenchyma, calices, and 
pelvis) involving flank pain, tenderness, and fever, and often associated with 
dysuria, urgency, and frequency. May be acute or chronic. 
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Urethritis: 
 Lower urinary tract inflammation without bacterial infection, causing 
symptoms similar to those of cystitis. But it can also be associated with 
bacterial infections producing sexually transmitted diseases such as 
Chlamydia trachomatis and Neisseria gonorrhea.  
Prostatitis:  
 Encompasses several different clinical entities, from bacterial 
infection to inflammation to pain, which cause symptoms related to the 
prostate gland. Chronic bacterial prostatitis is a remitting condition with 
variable symptoms present for more than 3 months. 
Leukocyturia: 
 Leukocytes (white blood cells) are found in the urine 
Uncomplicated urinary tract infection: 
 Infection in a patient with a normal, unobstructed genitourinary tract 
with no prior instrumentation. 
Complicated urinary tract infection: 
 Infection in a patient with structural or functional abnormalities. This 
also includes men, pregnant women, children, presence of foreign body 
(urinary catheter, stone, tumour) and sometimes upper urinary tract 
infection.  
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Relapse: 
 Recurrence of bacteriuria with the same microorganism present 
before initial therapy was started, due to persistence of the organism in the 
urinary tract. 
Reinfection: 
 Recurrence of bacteriuria with a new microorganism. Reinfection is 
difficult to differentiate from relapse when infection occurs with a 
microorganism of the same species as the initial infection. 
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Urinary tract infection 
Historical remarks 
Curtis Nickel made an historical review of urinary tract infections in 
2005; some key points are presented below: From ancient China (3000-2000 
B.C.) there are texts discussing the inspection of urine as an important 
diagnostic tool. In classical Greece, Hippocrates gave detailed descriptions 
of medical conditions in the kidneys and urinary tracts, and in ancient Rome 
Celsius (24) provided a detailed explanation of urinary catheterisation using 
bronze catheters. Aetius from Amida (Middle East, 500 A.D.) described 
urine examination (uroscopy) for clarity, colour, smell, cloudiness and 
presence of deposits and blood. It was then practiced in Europe for hundreds 
of years, until the time of the Renaissance. In the Renaissance 
(approximately 1500 to 1750), there were advances in anatomy and surgery 
but it was not until the 19th century that an understanding of disease etiology 
emerged. As for infectious diseases, Dutch microscopist Antony van 
Leeuwenhoek in the 17th century had managed to see small microorganisms,  
but it was not until the mid- 19th century that the etiology of infectious 
disease began to be clarified. 
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The intestinal bacterium Escherichia coli (E. coli), the most common 
and important bacterial species in urinary tract infections, was discovered in 
1885 by German pediatrician Theodor Escherich, and later named after him. 
Despite the discovery of bacteria as the cause of infectious diseases, it 
took many years for it to be understood that bacteria could cause diseases in 
the urinary tract. Around the turn of the twentieth century antiseptics were 
coming into use for urinary tract infections, but more successful treatments 
were not available until the introduction of sulphanilamide in 1937 (25).  
Sulphanilamide was effective for treatment of infections in the urinary tract 
but was unfortunately associated with serious side effects, substantially 
reducing its therapeutic usefulness. Nitrofurantoin, still in first line use 
today, was introduced as early as 1953 as a safe and effective treatment for 
uncomplicated urinary tract infections. In 1962, nalidixic acid, a prototype to 
the fluoroquinolones, was introduced. Trimethoprim and β-lactams 
(ampicillin, mecillinam and cephalosporins) effective for treatment of 
urinary tract infections, came in to use in the 1970s. 
Diagnosis by Kass’ criteria: 
In the 1950s, American microbiologist Edward Kass (26) carried out 
classical studies on the interpretation of quantitative urinary cultures in 
relation to the diagnosing of urinary tract infections in an attempt to sort out 
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those cultures that were not truly positive but only contaminations. Kass 
studied women with pyelonephritis (27) and women without symptoms of 
urinary tract infection. In women with pyelonephritis, 95% had a urinary 
bacterial count of ≥108 colony forming units/litre (cfu/L) while most 
asymptomatic women had no bacterial growth or a bacterial count of <106 
cfu/L even in repeated cultures, giving a dividing line between the true 
bacteriuria in pyelonephritis and contaminated samples in asymptomatic 
subjects. Kass’ findings resulted in the concept of significant bacteriuria 
(≥108 cfu/L), as a diagnostic indication of urinary tract infection; smaller 
bacterial counts were regarded as contaminations (Kass’ criteria). However, 
some of the asymptomatic women were also found to have a urinary 
bacterial count of ≥108 cfu/L, and this result was verified in repeated, 
consecutive samples from the same individuals, confirming the presence of 
asymptomatic bacteriuria.  
Epidemiology 
Urinary tract infections are one of the most common bacterial 
infections (1) in humans. They are common among sexually active women 
and, except in the first months of life, more common in women than in men. 
In adult women the incidence of urinary tract infection in 12 months is 10.8-
13.3% and the lifetime risk of urinary tract infection in women is estimated 
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at 50- 60%. The highest incidence rate is seen in women aged about 20, after 
which there is a slow decrease toward middle age and then a gradual 
increase from about 65 years of age. In young men the 12 month incidence 
of urinary tract infection is only about 1%, but increases from about 65 years 
of age to 7-8% above 80 years. However, in old age the population of 
women is markedly larger than that of men. Consequently, women account 
for a proportionally larger proportion of the urinary tract infections treated in 
the health care system. This fact also in part explains studies on women 
being more common than on men, resulting in inferior knowledge about men 
and urinary tract infections. As urinary tract infections are often transient 
and self-healing, the real incidence in younger populations is probably 
higher. In contrast, the high occurrence of asymptomatic bacteriuria may 
result in over-estimation of the real incidence of symptomatic urinary tract 
infections in the elderly. 
 Recurrent urinary tract infections are common, and the majority of 
people having urinary tract infections have a history of two or more such 
infections in their lifetimes. There are subpopulations that are more prone to 
developing urinary tract infections, such as pregnant women (28), patients 
with catheters, and patients with spinal cord injuries, diabetes, multiple 
sclerosis or HIV infection. Among non- institutionalized elderly people (37), 
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genitourinary infections are the second most common infections (after 
respiratory tract infections), accounting for nearly 25% of all infections. 
Clinical presentations 
The most common presentation of symptomatic urinary tract infection 
is acute cystitis, which constitutes approximately 90% of the episodes of 
urinary tract infections. Acute cystitis is an infection engaging the lower 
urinary tract, resulting in an inflammatory response in the bladder and 
urethra, causing leukocyturia and focal symptoms such as dysuria (painful 
urination), urgency (sudden compelling desire to urinate) and frequency 
(frequent urination). The diagnosis in women is based primarily on typical 
symptoms, and a urinary test is in most cases unnecessary.  
Although the symptoms of acute cystitis can be very troublesome, it is 
generally innocuous and self-healing, and the primary reason for antibiotic 
treatment is to shorten the time with symptoms. Untreated acute cystitis only 
occasionally progresses to pyelonephritis. In acute pyelonephritis the 
infection involves the kidneys and causes focal symptoms such as flank pain 
and signs of systemic inflammation with fever and general malaise. In 
pyelonephritis there are sometimes, but not always, concomitant symptoms 
from the lower urinary tract. Focal symptoms from the upper urinary tract 
are sometimes absent, especially among elderly patients, and the only 
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symptom may be fever and general malaise. Bacteraemia (occurrence of 
bacteria in the blood) is found in 20- 30% of patients with febrile urinary 
tract infections. Signs and symptoms of urinary tract infection in men are 
similar to those in women. Major predisposing factors are genitourinary 
instrumentation and urinary obstruction due to prostatic hypertrophy. In 
addition to these clinical presentations of symptomatic urinary tract 
infections, there is sometimes bacteriuria (bacteria in the urine) in a subject 
with no symptoms of a urinary tract infection i.e., asymptomatic bacteriuria. 
Asymptomatic bacteriuria 
Definition 
According to the most common definition, asymptomatic bacteriuria 
(4) occurs in a patient when, without symptoms of urinary tract infection, in 
two voided consecutive urine samples, he or she shows growth of the same 
bacterial strain with a count of ≥108 cfu/L. In men, there is support for the 
use of a definition of only one voided sample with growth of ≥108 cfu/L to 
confirm asymptomatic bacteriuria. This applies even for men using a freshly 
applied condom catheter. 
A urine sample obtained by urethral catheterization showing one 
bacterial species with a count ≥105 cfu/L identifies asymptomatic bacteriuria 
in both women and men. 
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Prevalence 
The prevalence of asymptomatic bacteriuria in schoolgirls is about 
1%, in women up to 50 years, including pregnant women, 1-5% (22). From 
about 50 years of age the prevalence increases from 3 to 9% to around 20% 
in women aged 80 and over. Asymptomatic bacteriuria, like symptomatic 
urinary tract infections, is more prevalent among sexually active women. 
Asymptomatic bacteriuria is uncommon in young men (<1%) but the 
prevalence increases from the age of 60 up to 5-10% in men aged 80 and 
over.  
In the elderly (22) living in institutions asymptomatic bacteriuria is very 
common. In women, the prevalence is found to be 25-50% and in men 15- 
40%. These figures vary depending on differences in populations studied, 
and whether one or two cultures were required for diagnosing asymptomatic 
bacteriuria. In women and men who have chronic indwelling urinary 
catheters, the prevalence of bacteriuria is almost 100%.  
In women with diabetes the prevalence of asymptomatic bacteriuria is 
higher than in age-matched non-diabetic women, while diabetic and 
nondiabetic men seems to have asymptomatic bacteriuria to the same extent. 
Although asymptomatic bacteriuria is often transient in young and middle-
aged women, as in elderly women and men, a considerable proportion of 
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individuals have bacteriuria repeatedly. In young girls, persistent 
asymptomatic bacteriuria (Escherichia coli) was mostly attributable to 
infection with the same bacterial strain, and a change of strain was often a 
result of antibiotic treatment. 
Clinical importance 
Children 
Asymptomatic bacteriuria in children is well investigated. It may 
persist for many years without evidence of any adverse outcomes. In 
children there are in fact indications that asymptomatic bacteriuria may 
prevent infections with more virulent bacterial strains, and that antibiotic 
treatment may increase the risk of symptomatic urinary tract infections. 
Therefore, screening for, and treatment of asymptomatic bacteriuria in 
children is not recommended. 
Young and middle-aged women 
The prevalence of asymptomatic bacteriuria in young and middle-
aged women increases with age. Known risk factors are, like for 
symptomatic urinary tract infections, sexual intercourse and use of 
diaphragm or spermicides as birth control measures. The prevalence of 
asymptomatic bacteriuria in sexually active women is 3-5 times higher than 
in women in the same age groups who are not sexually active.  
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There was also, in long-term follow-up (of about 15 years), an 
increased risk of developing symptomatic urinary tract infections as 
compared with women without bacteriuria. 
 Antimicrobial treatment of women with asymptomatic bacteriuria 
resulted in temporary cure in the treatment group but after one year the 
prevalence of bacteriuria was the same in the antibiotic and placebo groups, 
and equal proportions of the two groups were identified with symptomatic 
urinary tract infections during the year of follow-up. 
In conclusion, young and middle-aged women with asymptomatic 
bacteriuria more often experienced symptomatic urinary tract infections and 
recurrent episodes of asymptomatic bacteriuria. This group of patients forms 
the predominant group of people presenting with asymptomatic bacteriuria. 
However, antimicrobial treatment did not decrease the number of 
symptomatic infections, and asymptomatic bacteriuria was not associated 
with any negative long-term side effects. Thus, asymptomatic bacteriuria in 
young and middle-aged women need not be screened for or treated with 
antibiotics. 
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 Pregnant women 
Pregnant women with untreated asymptomatic bacteriuria are at 20-30 
times higher risk of developing pyelonephritis later in pregnancy than 
women without bacteriuria. These women also may have an increased risk 
for premature delivery and of having babies with low birth weight. Whether 
this is an independent risk or associated with the development of 
pyelonephritis is controversial. Antibiotic treatment is effective in reducing 
the high rate of pyelonephritis in pregnancy and thus screening for and 
treatment of asymptomatic bacteriuria in pregnancy is warranted. 
Elderly living in the community 
There are several long-term studies including elderly people where the 
effects of asymptomatic bacteriuria on morbidity and mortality have been 
evaluated without finding any adverse outcomes. 
A randomised placebo-controlled clinical trial including ambulatory 
elderly women reported a lower prevalence of asymptomatic bacteriuria and 
follow up for six months of these patients showed no significant difference 
in the mortality or morbidity in the same period. Thus, screening for and 
treatment of asymptomatic bacteriuria in elderly people living in the 
community is not warranted. 
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Institutionalised elderly 
Asymptomatic bacteriuria is very common among the institutionalized 
elderly. The occurrence of asymptomatic bacteriuria in this population has 
been shown to be associated with dementia and impaired functional status,  
including incontinence of urine and bowel. 
An important cause of bacteriuria in this group is thought to be 
impaired bladder voiding owing to degenerative or vascular diseases, and in 
men urinary obstruction secondary to prostatic hypertrophy and even chronic 
infective prostatitis. However, the causality is not fully clarified. 
Antibiotic treatment for asymptomatic bacteriuria in this population 
did not affect mortality in women or men, did not decrease the numbers of 
symptomatic urinary tract infections, did not reduce chronic urogenital 
symptoms, and did not positively affect physical and mental functioning. On 
the contrary, antibiotic treatment gave adverse effects and an increase in the 
number of bacteria resistant to antibiotics making it obvious that treatment 
of asymptomatic bacteriuria in the elderly living in institutions is of no 
benefit. 
Diabetes 
People with diabetes have an increased risk of developing both 
asymptomatic bacteriuria and symptomatic urinary tract infections, and the 
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symptomatic infections tend to be more severe than in non-diabetic subjects. 
Antibiotics have no role in the treatment of asymptomatic bacteriuria in 
diabetics and they do not have any role in delaying the progression of renal 
disease. 
 
CATHETER ASSOCIATED URINARY TRACT INFECTIONS 
Introduction 
Catheter-associated urinary tract infection (CAUTI) is the most 
common nosocomial infection in hospitals and nursing homes world-wide 
constituting approximately 40% of nosocomial infections. Most patients 
with nosocomial urinary tract infections (UTI`s) have either had 
genitourinary or urological manipulation or permanent urethral 
catheterisation, or both. Most catheter associated urinary tract infections 
derive from the patient’s own colonic flora. Nosocomial bacteriuria or 
candiduria develops in up to 25% of patients requiring a urinary catheter for 
> 7 days, with a daily risk of 5%. Most Catheter-associated urinary tract 
infections are asymptomatic and rarely extend hospitalization, but 
asymptomatic infections often precipitate unnecessary antimicrobial therapy. 
Catheter-associated urinary tract infections comprise perhaps the largest 
institutional reservoir of nosocomial antibiotic-resistant pathogens, the most 
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important of which are multidrug-resistant Enterobacteriacae other than 
Escherichia coli, such as Klebsiella, Enterobacter, Proteus, Citrobacter, 
Pseudomonas aeruginosa, enterococci, staphylococci and Candida. 
History 
In the 1920s, Foley introduced the self-retaining catheter. Initially it 
was used with open drainage, and bacteriuria was virtually universal by the 
end of the fourth day. With the introduction and development of modern 
biomaterials technology and the design of suitable receptacles, closed-
catheter systems were introduced. Development of bacteriuria was delayed 
but was still universal after 5 to 7 days. A recent relaxation of the closed-
system principle occurred with the development of a so-called flip (non-
return) valve, allowing a patient to void intermittently on demand through an 
open catheter. 
INDICATION FOR CATHETERISATION 
1. Investigations and Diagnostic Purposes 
a) To determine residual Urine 
b) To enable bladder function test to be performed 
2. Drainage  
Pre or Post – Operatively, i.e.  
a)  To drain blood clots and debris. 
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b)  To obtain an accurate measurement of urine output. 
c)  To empty the bladder before childbirth if necessary. 
3. Retention of Urine 
Acute or Chronic caused by:- 
a) Outflow obstruction e.g. Prostate Hyperplasia or Urethral 
Stricture. 
b) Neurological diseases e.g. Multiple Sclerosis. 
c) Trauma to brain or spinal cord. 
d) Spina Bifida. 
4. Drug Instillation 
a)  Catheter Maintenance Solution 
b) Chemotherapy 
5. Management of Incontinence. 
Definition of Catheter associated urinary tract infection 
Most clinicians use a clean-voided specimen showing >105 CFU/ mL 
as the criterion for “significant” bacteriuria for noncatheterized patients. 
However, once any microorganisms are identified in urine from a patient’s 
indwelling catheter, unless suppressive antimicrobial drug therapy is being 
given or started, progression to concentrations >105 CFU/mL occurs 
predictably and rapidly, usually within 72 hours. Thus, most authorities 
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consider concentrations >102 or 103 CFU/mL (2), in urine collected with a 
needle from the sampling port of the catheter, to be indicative of true 
Catheter associated urinary tract infection. This concentration can be 
reproducibly detected in the laboratory, and this definition is useful for 
therapeutic decisions and epidemiologic research. 
Pathogenesis 
The urethral catheter can inhibit or bypass certain defense 
mechanisms that would normally prevent or minimize bacteria–epithelial 
cell interactions, e.g. the glycosaminoglycan (GAG) layer by biofilm 
formation. 
Bacteria can enter the urinary tract in catheterized patients at the time 
of catheter insertion. This is especially common in patients who have 
inadequate cleansing of the perineum and distal urethra; especially in 
patients on intermittent clean catheterization where only a limited attempt is 
made to cleanse the entry points before introduction of the catheter. Up to 
20% of individuals will be colonised immediately after catheterization. In 
males the predominant route of invasion is the intraluminal, suggesting an 
exogenous source. It is demonstrated that the intraluminal ascent of bacteria 
is faster (32–48 h) than the extraluminal route (72–168 h). The taps of the 
urine drainage bags commonly become contaminated during use and their 
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regular opening to drain the urine also affords the bacteria access to the bag 
and migrate to the drainage tube, the catheter and bladder right after. 
Disconnection of the catheter from the drainage tube has also been shown to 
lead to contamination of the system. 
Catheterization will promote the development of a biofilm between 
the catheter and urethral mucosa. This provides a favourable environment 
for bacterial invasion and proliferation via the extraluminal route. A greater 
proportion of bacteriuria is found in women (70–80%) than in men (20–
30%).  
Biofilm is defined as an accumulation of microorganisms and their 
extracellular products that form a structured community on a solid surface. 
Biofilms are ubiquitous. In the context of urological practice they can be 
demonstrated on catheters, drainage bags and other foreign bodies and 
prostheses.  
Biofilm is composed of three layers: (i) the linking film, attached to 
the surface tissue or biomaterial; (ii) the basal layer; and (iii) the surface film 
adjacent to the lumen, from which planktonic organisms can be released. 
Organisms within the biofilm are well protected from mechanical flushing 
by urine flow, other host defences and antibiotics. Bacteria with specialized 
structures like fimbriae and pili are more prone to cause urinary tract 
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infection. Conventional laboratory testing can easily detect planktonic free-
floating bacteria within the urine or occasionally in the tissue. However, 
sessile pathogens from the biofilm will not be detected with routine 
methods. 
Microorganisms in catheter associated urinary tract infection 
The most common infecting organisms in catheter associated urinary 
tract infection are the Enterobacteriaceae. In most reports, Escherichia coli is 
the most common organism isolated from women, and Proteus mirabilis is 
the most frequent in men. Recently three studies have proven that Klebsiella 
pneumoniae is the most common organism in catheter associated urinary 
tract infection. Other organisms frequently isolated include Citrobacter 
species, Enterobacter species, Serratia species, Providencia stuartii, 
Morganella morganii, and Pseudomonas aeruginosa. Enterococcus species 
and group B streptococci are the most frequently isolated gram-positive 
organisms, and Candida species also may cause infection. Polymicrobial 
bacteriuria is identified in 10% to 25% of both men and women. Organisms 
isolated from urinary tract infection tend to have increased antimicrobial 
resistance relative to those isolated from elderly subjects in the community. 
This observation reflects repeated exposure to antimicrobials in a given 
individual with recurring infection, as well as the intense use of 
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antimicrobials in catheter associated urinary tract infection, together with 
opportunities for transmission of organisms among patients. Providencia 
stuartii is one organism that may be highly resistant and appears to have a 
unique institutional predilection.  
Symptoms 
Symptoms are also not reliable for the diagnosis of catheter-associated 
urinary tract infection. Most catheter-associated urinary tract infections are 
asymptomatic. Part of the reason for the absence of symptoms of urethral 
irritation such as dysuria or supra-pubic pain is that the catheter itself 
prevents contact of inflammatory cells in urine and large numbers of 
microorganisms with the urethral mucosa. The presence of the urinary 
catheter in situ also allows for decompression of the bladder, thus preventing 
the development of symptoms related to bladder distension or reflux. It is 
interesting to note that the majority of cases of bloodstream infection and 
mortality associated with catheter-associated urinary tract infections are in 
patients where there is significant urinary obstruction. It has also been 
shown that patients with long-term indwelling catheters rarely have febrile 
episodes even though they have chronic significant amounts of bacteria in 
their urine. This changes when obstruction or encrustation occurs as in that 
setting, decompression of the infected bladder is compromised. 
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Methods of catheterisation and the risk of urinary tract infection  
Single (straight) catheterisation 
After single (straight) catheterisation, bacteriuria develops in 1–5% of 
cases. The risk of infection is increased in female patients, patients with 
urinary retention, in peripartum catheterisation, in men with prostatic 
obstruction, in diabetes mellitus and in debilitated and elderly patients. 
 Short-term catheterisation 
Short-term catheterization is usually defined as catheter in place for 
less than 7 days. Indications for short-term bladder catheterisation are to 
monitor urine output (i) in acutely ill patients, (ii) for urinary obstruction and 
(iii) in the perioperative period. Between 15% and 25% of patients admitted 
to hospital may be catheterised for 2–4 days during their stay. Between 10% 
and 30% will develop bacteriuria. 
Most episodes of short-term catheter-associated bacteriuria are 
asymptomatic and are caused by single organism; 15% may be 
polymicrobial, reflecting the prevailing flora in hospital or community 
environments. Therefore, the most common species are Escherichia coli, 
Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus mirabilis, 
Staphylococcus epidermidis, Enterococcus and Candida. Most catheter-
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associated bacteriuria is accompanied by pyuria which however varies by 
organism. 
Although there is extensive literature on the type, maintenance and 
techniques for the insertion of urinary catheters, little attention is paid to 
their removal. The importance of short-term urethral catheter management is 
recognised; however, there is no consensus about the optimal time and 
method for removal of indwelling urethral catheters. Fewer urinary tract 
infections occurred when the catheter was removed as soon as possible. 
 Long-term catheterisation 
When indwelling catheterization lasts for more than 28 days it is 
defined as ‘long-term’ or ‘chronic’. Unfortunately, there is no consensus on 
the classification of indwelling catheters in place for 8-27 days. The 
commonest infecting organism is Escherichia coli. Persistence is related to 
the presence of type 1 pili, an adhesin for uroepithelium and the Tamm–
Horsfall protein. Other associated flora includes Pseudomonas, Proteus, 
Morganella, Acinetobacter, Enterococcus and Candida. Bacteriuria is 
polymicrobial in up to 95% of urine specimens from long-term catheterised 
patients. One- quarter of organisms in catheter urine are not present in urine 
simultaneously obtained by suprapubic bladder puncture, suggesting that 
some organisms colonize the catheter only.  
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Transient asymptomatic bacteraemia is common during initial catheter 
insertion or during catheter exchange in chronically catheterised patients. 
The relatively low incidence of febrile urinary tract infection and 
bacteraemia may be due to the fact that colonization of urethral catheters is 
caused mainly by less virulent organisms. It has been shown that colonizing 
Escherichia coli strains lack P fimbriation in a catheter-associated infection. 
The contribution of catheter-associated urinary tract infection to 
mortality is unclear. The contributable mortality varies between 9% and 
13%. Other risk factors include severity of co-morbid disease, inappropriate 
antibiotic therapy, remote infection and the presence of an unrecognised 
urological abnormality. Chronic catheterisation can lead to obstruction of the 
lower urinary tract owing to catheter blockage as well as to urinary tract 
stones, epididymitis and prostatitis. Up to 50% of patients undergoing 
catheterisation for more than 28 days experience recurrent encrustation and 
catheter blockage. Intermittent urinary retention can lead to vesicoureteric 
reflux and ascending complicated infection. Infecting organisms often 
include Proteus mirabilis, a potent urease producer, which promotes the 
development of struvite stones by hydrolysis of urea to ammonium. Bladder 
catheterisation for more than 10 years, e.g. in patients with spinal cord 
injury, may be associated with an increased risk of bladder cancer (51). 
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 Alternative methods of urine drainage 
Prevention of catheter associated infection may be accomplished by 
alternatives to indwelling catheterisation. 
Intermittent catheterisation 
Intermittent catheterisation (48) is popular in the management of 
voiding dysfunction due to a wide variety of causes, including a neuropathic 
bladder. It is a safe and effective method of bladder management for four 
groups of patients: children with neuropathic bladder dysfunction (e.g. spina 
bifida); women with incontinence caused by uncontrolled reflex detrusor 
contraction; women and men with urinary retention due to ineffective or 
absent detrusor contraction; and males with bladder outlet obstruction who 
are not fit for surgery. Bacteriuria is acquired at the rate of 1–3% per 
catheterisation. Therefore it is universal by the end of the third week. It may 
be expected that local periurethral infection, febrile episodes, stones and 
deterioration of renal function are less common than in patients permanently 
catheterised. Complications include bleeding, urethral inflammation, 
stricture, false passage, epididymitis, bladder stone and hydronephrosis. 
Suprapubic catheterisation 
Suprapubic catheterisation (19) is used mainly in patients undergoing 
urological or gynaecological procedures. According to the several studies 
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there is evidence that suprapubic catheters are superior to indwelling urethral 
catheters in terms of bacteriuria (asymptomatic and symptomatic) and re-
catheterisation.  
Condom catheters 
Condom catheters (47) can be useful in male patients without outlet 
obstruction. However, condom drainage may be unsatisfactory in confused 
or uncooperative patients or where there is obesity or a short penis. Skin 
maceration and ulceration can occur. Daily changing of the condom catheter 
is recommended, although changes every other day are not associated with 
increased infection rates. Condom catheters offer a lower incidence of 
bacteriuria compared with long-term urethral catheterisation. 
Urethral stents and prostheses 
Urethral stents and prostheses are often inserted into the prostatic 
urethra for a variety of indications, including neurogenic bladder 
dysfunction, prevention of strictures, and treatment of urinary retention. 
Bacteriuria, which is usually asymptomatic, occurs in 10–35% of patients.   
 
 
 
 29
Advantages and disadvantages of various catheter modalities for 
drainage purposes 
Procedure Advantages Disadvantages 
 
 
Transurethral indwelling 
catheter 
-catheters with several 
luminal sizes. 
-special catheters for 
flushing the bladder and 
for permanent bladder 
irrigation. 
- Catheter insertion 
usually not very 
traumatic using optimal 
technique. 
- only few 
contraindications, e.g. 
urethral stricture, urethral 
trauma 
-local infection 
(Urethritis) 
-urethral trauma, stricture 
and paraurethral abscess 
-prostatitis, epididymitis, 
pyelonephritis, urosepsis 
-high rate of nosocomial 
urinary tract infection 
-residual urine 
measurement not 
possible 
 
 
Intermittent 
catheterisation 
-less local periurethral 
infection, febrile 
episodes, stones and 
deterioration of renal 
failure 
-clean catheterization 
-elevated urethral trauma 
-urethral stricture 
-false passage 
-Urethritis, epididymitis, 
prostatitis 
-cooperative and skilled 
patient 
-difficult process in men 
 
 
Suprapubic catheter 
-no Urethritis, prostatitis, 
epididymitis 
-no Urethritis, prostatitis, 
epididymitis 
-lower rate of nosocomial 
UTI 
-spontaneous micturition 
and residual urine 
measurement 
-transurethral diagnostic 
procedures, cystoscopy, 
urethrogramme 
-installation by physician 
-Relative 
contraindications 
-bladder shrinkage 
-suprapubic scars 
-meteorism 
-pregnancy 
-obesity 
-Absolute 
contraindications: 
– bladder volume <200 
ml 
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-less troublesome for the 
patient 
– bladder tumor  
–anticoagulation therapy, 
haemorrhagic tendency, 
gross haematuria 
– skin diseases in the 
puncture area 
 
Condom catheter 
 
-lower incidence of 
bacteriuria 
-no urethritis, prostatitis, 
epididymitis 
-no urethral stricture 
-less painful procedure  
 
 
-cooperative and skilled 
patient 
– obesity 
– short penis 
– skin maceration and 
ulceration 
 
 
Urethral stent/prosthesis 
 
-lower incidence of 
bacteriuria 
-less urethral stricture 
-less troublesome for the 
patient 
 
-difficulty in proper 
placement, changing or 
removal 
-high level of scar 
formation 
-secondary stricture 
calcification  
 
RISK FACTORS FOR CATHETER ASSOCIATED URINARY 
TRACT INFECTION 
The most important risk factors have been prolonged catheterization 
and females are more at risk for catheter associated urinary tract infection. 
Other risk factors identified have included catheterization outside the sterile 
environment of the clinical room, patients with urinary tract abnormality, 
other infections, diabetes, malnutrition and renal failure. Interestingly, most 
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of the infection control interventions were found to have a minimal impact 
on the incidence of catheter associated urinary tract infection with one 
exception – if the drainage tube was allowed to be above the level of the 
patient; that was a major risk factor for infection. Antibiotics were in general 
protective, but the infections (when they occurred) tended to be caused by 
antibiotic-resistant organisms. 
Risk factors for catheter associated urinary tract infection based 
on a study by Dennis G. Maki and Paul A. Tambyah Emerging 
Infectious Diseases Vol. 7, No. 2, March–April 2001 
 
Factor                                                                            Relative risk 
 
Prolonged catheterization >6 days                                   5.1-6.8 
 
Female gender                                                                  2.5-3.7 
 
Catheter insertion outside operating room                       2.0-5.3 
 
Other active sites of infection                                          2.3-2.4 
 
Diabetes                                                                            2.2-2.3 
 
Malnutrition                                                                      2.4 
 
Azotemia (creatinine >2.0 mg/dL)                                   2.1-2.6 
 
   Urethral stent                                                                    2.5 
 
  Monitoring of urine output                                                2.0 
 
  Drainage tube below level of bladder                                1.9 
   and above collection bag 
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GUIDELINES FOR PREVENTING CATHETER ASSOCIATED 
URINARY TRACT INFECTION 
Several catheter care practices are universally recommended to 
prevent or at least delay the onset of catheter associated urinary tract 
infection: avoid unnecessary catheterizations; consider a condom or 
suprapubic catheter; have a trained professional insert the catheter 
aseptically; remove the catheter as soon as no longer needed; maintain 
uncompromising closed drainage; ensure dependent drainage; minimize 
manipulations of the system; separate catherised patients; and consider 
adopting a novel anti-infective catheter. However, few of these practices 
have been proven to be effective by randomized controlled trials. 
Avoid Unnecessary Catheterizations 
Use of indwelling urethral catheters should be limited to patients (62) 
requiring relief of anatomic or physiologic outlet obstruction; patients 
undergoing surgical repair of the genitourinary tract (to facilitate healing); 
critically ill or postoperative patients who need their urinary output 
accurately measured; and debilitated, paralyzed, or comatose patients (to 
prevent skin breakdown and infected pressure ulcers). When no longer 
needed, the catheter should be promptly removed. 
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Consider Alternatives to Urethral Catheterization 
Suprapubic catheterization is more comfortable and acceptable to the 
patient and may be associated with a lower incidence of catheter associated 
urinary tract infection. For incontinent males who do not have bladder outlet 
obstruction, condom drainage, while not free from nosocomial urinary tract 
infections, appears to be associated with a lower risk than indwelling 
urethral catheters. 
Insertion Using Aseptic Technique 
Catheters should be inserted by trained health-care professionals using 
aseptic technique, including sterile gloves, a fenestrated sterile drape, and an 
effective cutaneous antiseptic, such as 10% povidone-iodine or 1% to 2% 
aqueous chlorhexidine. 
Closed Drainage 
After a catheter is inserted, uncompromising maintenance of closed 
drainage is of the highest priority and can keep the overall risk of catheter 
associated urinary tract infection <25% for up to 2 weeks of catheterization. 
Ensure Dependent Drainage 
The collection tubing and bag should always remain below the level 
of the patient’s bladder, but the drainage tubing should always be above the 
level of the collection bag. 
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Urine Collection 
The catheter and the drainage system should be manipulated as little 
as possible, and urine output should be monitored hourly, only when clearly 
indicated by the patient’s condition. 
Other Practices 
If feasible, separating catheterized patients geographically on a 
patient-care unit may reduce the risk of cross infection with multidrug-
resistant nosocomial organisms such as Serratia, Klebsiella, Pseudomonas, 
and Enterobacter. Systemic antimicrobial prophylaxis with trimethoprim-
sulfamethoxazole, methenamine mandelate or a fluoroquinolone can reduce 
the risk of catheter associated urinary tract infection for short-term 
catheterizations. Although use of antimicrobials in this way may reduce the 
rate of catheter associated urinary tract infections, infections that do occur 
are far more likely to be caused by antibiotic-resistant bacteria and yeasts. 
Since most catheter associated urinary tract infections are asymptomatic and 
do not result in urosepsis, it is difficult to justify antimicrobial therapy of 
asymptomatic bacteriuria other than for granulocytopenic or other severely 
immunocompromised patients, patients scheduled for urologic surgery, 
pregnant women, patients with Serratia catheter associated urinary tract 
infection, or patients about to have their catheter removed. The societal 
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benefits of antibiotic prophylaxis in immunocompetent catheterized patients 
to prevent largely asymptomatic catheter-associated urinary tract infection 
are dubious. 
Silver-coated catheters 
Silver (16) is a well-known antiseptic with a long history, as an 
antiseptic rather than an antibiotic and the risk of generating antibiotic 
resistance would be expected to be low. Argyrism is a potential concern that 
has limited the use of silver on the internal coating of catheters and possibly 
limited its efficacy. There are a number of studies that have evaluated silver 
coated catheters (17) including silver oxide catheters and silver alloy 
catheters. Though there is a controversy in the efficiency of silver oxide 
catheters a meta-analysis of silver alloy coated catheters suggests that they 
are beneficial. 
Antibiotic coated catheters 
Antibiotic coated catheters using a combination of rifampicin and 
minocycline have been used. The rifampicin-minocycline catheter was most 
effective in preventing catheter associated urinary tract infection caused by 
Gram-positive rather than Gram-negative bacteria thus limiting its practical 
efficacy. The concern has been in the development of antibiotic resistance. 
In many parts of the world, where Mycobacterium tuberculosis is endemic, 
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as in our country the widespread use of rifampicin coated catheters would be 
a cause for concern, if this was found to be associated with increased rates of 
drug-resistant tuberculosis. 
Silicone urinary catheter impregnated with chlorhexidine and triclosan: 
Silicone urinary catheter impregnated with chlorhexidine and triclosan 
(55) show prolonged efficacy against colonization with important 
uropathogens including drug resistant bacteria and Proteus mirabilis. This 
catheter may suppress the growth of pathogens associated with long-term 
catheterization, with a reduced risk of emergence of resistant organisms 
Novel Technology 
Technologic innovations to prevent nosocomial infection are most 
likely to be most effective if they are based on a clear understanding of the 
pathogenesis and epidemiology of the infection. Novel technologies must be 
designed to block catheter-associated urinary tract infection by either the 
extraluminal or intraluminal routes or both.  Technologic innovations have 
been proposed and evaluated during the past 25 years but have not proven 
conclusively beneficial. Among these innovations are using anti-infective 
lubricants when inserting the catheter; soaking the catheter in an anti-
infective antimicrobial-drug solution before insertion; regular metal 
cleansing or periodically applying anti-infective creams or ointments to 
 37
metals; continuously irrigating the catheterized bladder with an anti-
infective solution through a triple-lumen catheter; or periodically instilling 
an anti-infective solution into the collection bag. Bladder irrigation with 
antimicrobial drug solutions has not only shown no benefit for prevention 
but has been associated with a strikingly increased proportion of catheter-
associated urinary tract infections caused by microorganisms resistant to the 
drugs in the irrigating solution. Given the widely accepted importance of 
closed catheter drainage, efforts have been made to seal the connection 
between the catheter and collection tubing.  
Medicated catheters (35), which reduce adherence of microorganisms to 
the catheter surface, may confer the greatest benefit for preventing catheter-
associated urinary tract infection. Two catheters impregnated with anti-
infective solutions have been studied in randomized trials, one impregnated 
with the urinary antiseptic nitrofurazone (57) and the other with a new broad 
spectrum antimicrobial-drug combination (56), minocycline and rifampin. 
Both catheters showed a significant reduction in bacterial catheter-associated 
urinary tract infections. 
The universal presence of a biofilm on the surface of an infected 
catheter has prompted hope that coating the catheter surface with an 
antiseptic, such as a silver compound, might reduce the risk for catheter 
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associated urinary tract infection. However, silver oxide coated catheters, 
which had been initially reported to show promise, did not show efficacy 
when studied in large, well controlled trials. In one of the trials, male 
patients with the coated catheter who did not receive systemic antibiotics 
had a paradoxical and inexplicably increased risk for catheter-associated 
urinary tract infection. A silver hydrogel catheter has been developed that 
inhibits adherence of microorganisms to the catheter surface in vitro and the 
tested microorganisms include resistant enterococci, staphylococci, 
Enterobacteriaceae, Pseudomonas aeruginosa, and yeasts. Use of the silver 
hydrogel catheter was not associated with an increased incidence of 
infections caused by antibiotic resistant bacteria or Candida, and in vitro 
susceptibility testing of isolates from both treatment groups showed no 
infections caused by silver resistant microorganisms. Cost utility analysis 
indicates that use of this catheter could bring substantial cost savings to 
health care institutions. 
Treatment 
Treatment of asymptomatic bacteriuria 
Generally, asymptomatic bacteriuria should not be treated because 
bacteriuria will either not be eradicated or will return rapidly. However, 
antimicrobial therapy may contribute to the selection of resistant organisms 
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and to adverse reactions. There is no evidence that antimicrobial therapy 
decreases morbidity or mortality from urinary tract infection in catheterized 
patients, therefore systemic antimicrobial treatment of asymptomatic 
catheter associated bacteriuria is only recommended in the following 
circumstances:  
(i) patients undergoing urological surgery or implantation of 
prostheses; 
(ii) treatment may be part of a plan to control nosocomial infection due 
to a particularly virulent organism prevailing in a treatment unit; 
(iii) patients who have a high risk of serious infectious complications, 
e.g. patients who are immunosuppressed; and 
(iv) infections caused by strains causing a high incidence of 
bacteraemia, e.g. Serratia marcescens. 
If the catheter drains properly, routine urine cultures in asymptomatic 
catheterised patients are also not recommended because treatment generally 
is not necessary. Also, it has not been shown that an uropathogen cultured 
from an asymptomatic patient will be the causative organism when a 
symptomatic episode occurs. Following catheter removal in one-third to 
one-half of cases, the urinary tract will clear bacteria spontaneously. 
Spontaneous clearance occurs more commonly in women under 65 years of 
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age or when Staphylococcus epidermidis is the infecting organism. 
However, one study shows that elderly females may need treatment if 
bacteriuria does not resolve spontaneously or if symptomatic infection 
occurs. 
Treatment of symptomatic urinary tract infection: 
The most frequent clinical manifestation of symptomatic urinary tract 
infection in catheterised residents is fever. Some patients may also become 
septic with at least two of the followings symptoms: hypothermia, 
tachycardia (> 90/min), tachypnoea (>20/min and/or pCO2 <33 Hg mm), 
leucocytosis (>12/nl) or leucopenia (<4/nl). Since patients with long-term 
indwelling catheters always have positive urine cultures, a definite diagnosis 
of the source of infection remains problematic in a febrile or septic 
catheterized patient without localizing genitourinary symptoms and if not 
bacteraemic due to the same urinary pathogen. Urinary tract infection may 
be the source of fever; if there are no localising features such as obstruction, 
haematuria or costovertebral angle tenderness, alternative diagnoses must be 
considered. Observation, rather than immediate antimicrobial therapy, 
should be considered when the patient is clinically stable and the fever is of 
low grade. 
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Antibiotic treatment is recommended only in symptomatic infection 
(bacteraemia, pyelonephritis, epididymitis, and prostatitis). Systemic 
antibiotics should be used for catheterised patients who are febrile and 
appear to be ill, because of the possibility of urinary tract infection related 
bacteraemia or pyelonephritis. Owing to the likelihood of bacteria 
sequestered in a biofilm on the catheter surface, it may be reasonable to 
replace or remove the catheter if the indwelling catheter has been in place 
for more than 7 days before the therapy of symptomatic catheter-associated 
bacteriuria. After initiation of empirical treatment usually with broad-
spectrum antibiotics based on local susceptibility patterns, the choice of 
antibiotics may need to be adjusted according to urine culture results. 
Therefore, urine culture and in septic patients also blood culture, must be 
taken before any antibacterial therapy is started. Although there are no 
adequate clinical studies to guide the length of therapy for catheter related 
symptomatic urinary tract infection, antimicrobial treatment usually varies 
from 5 days to 21 days depending on the organism, co-morbid conditions 
and patient response. Chronic antibiotic suppressive therapy is not effective 
and generally not recommended. Catheterized urine cannot be permanently 
sterilised. Occasionally, the culture shows candiduria, which is usually 
asymptomatic and often resolves without treatment. In this case neither 
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systemic nor local (bladder irrigation) antifungal therapy is indicated, but 
removal of the catheter or stent should be considered. If the infection is 
associated with urinary symptoms or candiduria is the sign of a systemic 
infection, systemic therapy with antifungals is indicated. 
Prevention of cross-infection 
Healthcare workers should be constantly aware of the risk of cross-
infection between catheterised patients. They should observe protocols on 
hand washing and the need to use disposable gloves. The periurethral 
bacterial flora, surfaces of the catheter system and the persistent, huge 
reservoir of contaminated urine as well as the skin of the patient are sources 
for contamination of the hands of medical personnel who may carry the 
bacteria to other patients. This may be reduced by treating the catheterised 
urinary tract as an open wound. It is therefore essential to use gloves after 
hand washing in antiseptic solutions.   
The Future 
The first major advance for preventing catheter associated urinary 
tract infection since the wide scale adoption of closed drainage 35 years ago, 
is the development of catheters with anti-infective surfaces. These advances 
should not be considered as the final answer, however. Other technologies 
that should be pursued include new, more potent anti-infective materials; 
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microbe-impervious antireflux valves; urethral stents; conformable 
(collapsible) urethral catheters; and vaccines for enteric gram-negative 
bacilli and staphylococci. Antiseptics are far more likely than antibacterials 
to confer greater resistance to surface colonization and not to select for 
infection with antimicrobial drug resistant bacteria or yeasts. New surface 
technologies that release far greater quantities of ionic silver or other anti-
infective agents into the aqueous environment contiguous to the catheter 
surface might even prevent catheter associated urinary tract infections 
caused by intraluminal contaminants. In uncontrolled trials, urethral stents 
have provided a less-invasive alternative to catheter drainage for men with 
outlet obstruction caused by prostatic hypertrophy or cancer. A conformable 
catheter, with a collapsible intraurethral segment that may cause fewer 
traumas to the urethra, has been developed but has not been tested clinically 
and is not commercially available. These and other alternatives to the rigid 
urethral catheter, such as a condom catheter for female patients, need to be 
evaluated in controlled, randomized trials. The greatest hope for a major 
reduction in catheter associated urinary tract infections and indeed all 
nosocomial infections is likely to be vaccines against important nosocomial 
multidrug-resistant pathogens, such as the enteric gram-negative bacilli and 
staphylococci. 
 44
MATERIALS AND METHODS 
This study was conducted in Government Stanley Hospital. The study 
was conducted over a period of nine months from December 2007 to August 
2008. 
Patients who were catheterized for various disease conditions were 
taken for study. The patients were mainly from surgical wards like general 
surgery, orthopedics, neurosurgery and medical wards like neuromedicine, 
general medicine and intensive care unit. The patients were included in the 
study after getting informed consent from them or from their relatives. The 
primary diagnosis for which they were admitted was noted. 
Both males and females in age group of 20 to 70 years were included 
in our study. A total of 208 patients of which 105 were males and 103 were 
females were initially included in our study. 98 patients of which 48 were 
males and 50 were females were excluded from the study based on the 
exclusion criteria and finally a total of 110 patients were included in the 
study for analysis. 
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INCLUSION CRITERIA: 
Long term catheterized patients like: 
1. Fracture femur. 
2. Dislocation of hip. 
3. Traumatic and other causes of paraplegia. 
4. Cerebrovascular accidents. 
5. Neurodegenerative disorders. 
6. Various types of meningitis.   
7. Various types of encephalopathies. 
EXCLUSION CRITERIA: 
1. Patients who were urine culture and sensitivity positive on the day 
of catheterization. 
2. Patients in whom catheter was removed before the fourth day for 
various reasons like the patient’s general condition improved or the patient 
absconded from ward or went against medical advice or died. 
3. Patients in whom catheter was removed before the eight day and 
was urine culture and sensitivity negative on the fourth day for various 
reasons like the patient’s general condition improved or the patient 
absconded from ward or went against medical advice or died. 
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4. Patients who had symptoms suggestive of urinary tract obstruction 
and elderly male patients with prostatic hypertrophy and female patients 
with ultrasonographic evidence of pelvic inflammatory diseases and 
symptoms suggestive of atrophic vaginitis. 
A complete history and physical examination of the patients were 
made and the details recorded. Any previous history of chronic diseases like 
diabetes mellitus, hypertension, cardiac diseases, previous history of 
catheterisation or any other diseases was elicited and the details recorded. 
Blood samples were taken and sent for various analysis like blood sugar, 
urea, serum creatinine, serum electrolytes and complete blood count. 
Ultrasonogram of abdomen was also done and the findings recorded. 
After ensuring strict aseptic precautions urinary bladder was 
catheterised using adult size Foley’s catheter. The first drained urine sample 
was collected directly from the rubber tubing end, and sent for routine urine 
analysis and for culture and sensitivity and the reports were taken for 
analysis. 
On day four of catheterization, patients were examined for general 
physical status and history of fever, dysuria and abdominal pain was made 
and the details were recorded. Then urine sample was collected directly from 
the catheter after disconnecting from the draining tube and the sample was 
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sent for routine urine analysis and culture and sensitivity and the reports 
noted. Urine samples which showed organism growth of over 103 were 
considered significant and was reported positive by the microbiologist and 
drug sensitivity pattern for those samples were made and reported. The 
reports were then taken for our study analysis. 
A similar urine sample was collected on the eight day if the urine 
culture and sensitivity report on the fourth day was culture negative and the 
sample was sent for similar analysis as on the fourth day. The reports were 
then taken for our study analysis. 
All the data were recorded in the master chart and the reports were 
then taken for analysis. 
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RESULTS 
A total of 208 patients of which 105 were males and 103 were females 
were initially included in the study. 
The number of patients excluded was 98 of which 48 were males and 
50 were females. The details of exclusion are: 
Table I - Exclusion details of patients 
 
Exclusion details 
 
 
Male 
 
Female 
 
Total 
 
Urine culture positive on first day 
 
 
4 
 
7 
 
11 
 
Catheter removed before fourth day 
a. Patient improved 
b. Against medical advice 
c. Patient died 
 
 
11 
2 
5 
 
 
10 
3 
2 
 
 
21 
5 
7 
 
Catheter removed before eight day when 
urine culture negative on fourth day 
a. Patient improved 
b. Against medical advice 
c. Patient died 
 
 
 
14 
3 
4 
 
 
 
18 
6 
3 
 
 
 
32 
9 
7 
 
Patients with symptoms of urinary tract 
obstruction 
 
 
5 
 
1 
 
6 
 
Final total 
 
 
48 
 
50 
 
98 
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Table II - Number of patients in the study 
 
Patients initially included in study 
 
208 
 
Patients excluded from study 
 
98 
 
Total patients finally included in the 
study 
 
110 
 
Of the 110 patients, 105 were males constituting 52% and 103 were 
females constituting 48%. 
The patients included in the study were in the age group of 25 years to 
68 years with an average of 50 years. 
Table III - Age wise distribution of patients 
Age (Years) Number of patients 
25 - 35 6 
36 - 45 25 
46 - 55 43 
56 - 65 26 
66 - 75 2 
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Table IV - Indications for catheterization 
 
Diagnosis 
 
 
Number of patients 
 
 
Cerebrovascular accident 
 
16 
 
Neurodegenerative diseases 
 
10 
 
Encephalopathy 
 
11 
 
Meningitis 
 
 
10 
 
Transverse myelitis 
 
 
6 
 
Compressive myelopathy 
 
 
8 
 
Fracture femur 
 
 
12 
 
Fracture leg 
 
 
8 
 
Hip dislocation 
 
 
8 
 
Traumatic paraplegia 
 
 
8 
 
Bowel anastamosis 
 
 
9 
 
Abdominal surgery 
 
 
4 
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Among the 110 catheterized patients, 31 patients were urine culture 
and sensitivity positive on day 4 of catheterization constituting 28%and the 
remaining 79 patients were urine culture and sensitivity negative constituting 
72% .Of these 31 urine culture and sensitivity positive patients 14 were 
males and 17 were females. 
Among 79 patients who were urine culture and sensitivity negative, 
14 patients became urine culture and sensitivity positive on day 8. It 
constituted 41% of the total 110 patients. Among the 14 patients 6 were 
males and 8 were females. The percentage of increase in urine culture and 
sensitivity positivity from day 4 to day 8 was 18%. 
Table V – Urine culture reports 
 
 
Days of 
catheterisation 
 
Urine culture and 
sensitivity positive 
Number (%) 
 
 
Urine culture and 
sensitivity negative 
Number (%) 
 
At the end of day 4 of 
catheterization 
 
 
31 (28%) 
 
79 (72%) 
 
At the end of day 8 of 
catheterization 
 
 
45 (41%) 
 
65 (59%) 
 
From day 4 to day 8 of 
catheterization 
 
 
14 (18%) 
 
65 (82%) 
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Table VI - Sex wise distribution of Urine culture positive patients 
 
Urine culture positive 
 
Male 
 
 
Female 
 
Urine culture and 
sensitivity positive on 
day 4 Number (%) 
 
 
 
 
14 (45%) 
 
 
17 (55%) 
 
Urine culture and 
sensitivity positive on 
day 8 Number (%) 
 
 
 
 
20 (44 %) 
 
 
25 (56%) 
 
Urine culture and 
sensitivity positive from 
day 4 to day 8 Number 
(%) 
 
 
 
 
6 (43%) 
 
 
8 (57%) 
 
Among the 57 male patients 14 were urine culture and sensitivity 
positive on day 4 and 20 were urine culture and sensitivity positive on day 8. 
Among the 53 female patients 17 were urine culture and sensitivity positive 
on day 4 and 25 were urine culture and sensitivity positive on day 8. 
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Table VII - Sex wise risk for urine culture positivity 
 
Description 
 
Male Number (%) 
 
 
Female Number (%) 
 
Total patients in study 
 
 
57 (52%) 
 
53 (48%) 
 
Incidence of urine 
culture positivity on day 
4 of catheterization 
 
 
 
14 (25%) 
 
 
17 (32%) 
 
Incidence of urine 
culture positivity on day 
8 of catheterization 
 
 
 
20 (35%) 
 
 
25 (52%) 
 
 
Among the 31 urine culture positive isolates on day 4, 11 were 
Klebsiella pneumonia positive, 9 were Escherichia coli positive, 4 were 
Enterococci positive, 3 were Pseudomonas positive, 2 were Staphylococcus 
aureus positive, 2 were coagulase negative staphylococci positive. 
Among the 45 urine culture positive isolates at the end of day 8, 15 
were Klebsiella pneumonia positive, 13 were Escherichia coli positive, 5 
were Enterococci positive, 4 were Pseudomonas positive, 4 were 
Staphylococcus aureus positive, 3 were coagulase negative staphylococci 
positive and in 2 samples there was growth of Candida. 
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Table VIII - Distribution of microorganisms in urine culture 
positive isolates 
 
 
Organism grown 
 
On the fourth day 
urine sample (Total = 
31) Number (%) 
 
 
At the end of eighth 
day urine sample      
(Total = 45) Number 
(%) 
 
 
Klebsiella pneumonia 
 
 
11 (36%) 
 
15 (33%) 
 
Escherichia coli 
 
 
9 (29%) 
 
13 (29%) 
 
Enterococci 
 
 
4 (13%) 
 
5 (11%) 
 
Pseudomonas 
 
 
3 (10%) 
 
4 (9%) 
 
Staphylococcus aureus 
 
 
2 (6%) 
 
4 (9%) 
 
Coagulase negative 
staphylococci 
 
 
2 (6%) 
 
3 (7%) 
 
Candida 
 
 
 
0 
 
1 (2%) 
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In our study, Klebsiella pneumoniae was the most common organism 
isolated constituting 33%, followed second by Escherichia coli constituting 
29% and third by Enterococci constituting 11%. Candida constituted 2% of 
microorganism isolate in our study. 
Klebsiella pneumoniae that was isolated in the urine sample was 
sensitive to amikacin in 14 cases and resistant in 1 case, sensitive to 
gentamicin in 9 cases and resistant in 6 cases, sensitive to ciprofloxacin, 
norfloxacin, cefotaxime, cotrimoxazole in 6 cases and resistant in 9 cases 
and sensitive to erythromycin in 1 case resistant in 14 cases. 
Escherichia coli was sensitive to amikacin in 13 cases, sensitive to 
gentamicin and ciprofloxacin in 11 cases and resistant in 2 cases, sensitive to 
norfloxacin in 10 cases resistant in 3 cases, sensitive to erythromycin in 8 
cases resistant in 5 cases, sensitive to cefotaxime in 9 cases and resistant in 4 
cases and sensitive to cotrimoxazole in 6 cases and resistant in 7 cases. 
An important finding in our study was that almost all of the patients 
included in the study were put on some form of antibiotic like ampicillin, 
gentamicin, ciprofloxacin and cefotaxime from the first day of 
catheterization. But still there was occurrence of catheter associated urinary 
tract infection in the range of 45% at the end of eight day of catheterization.  
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Table IX - Drug sensitivity pattern for Klebsiella pneumoniae and 
Escherichia coli in our study 
 
Klebsiella pneumoniae 
(Total = 15) Number 
(%) 
 
 
Escherichia coli    
(Total = 13) Number 
(%) 
 
 
Antibiotic 
 
 
Sensitive Resistant Sensitive Resistant 
Amikacin 
 
14 (93%) 1 (7%) 13 (100%) 0 
 
Gentamicin 
 
9 (60%) 6 (40%) 11 (85%) 2 (15%) 
 
Ciprofloxacin 
 
7 (47%) 8 (53%) 11 (85%) 2 (15%) 
 
Norfloxacin 
 
6 (40%) 9 (60%) 10 (77%) 3 (23%) 
 
Cefotaxime 
 
6 (40%) 9 (60%) 9 (69%) 4 (31%) 
 
Erythromycin 
 
1 (7%) 14 (93%) 8 (61%) 5 (39%) 
 
Cotrimoxazole 
 
6 (40%) 9 (60%) 6 (46%) 7 (54%) 
 
This shows that amikacin was the antibiotic which was sensitive to 
most number of Klebsiella pneumoniae and Escherichia coli in our study. 
Similarly these organisms were resistant to a high proportion to the 
commonly used antibiotics like erythromycin and cotrimoxazole. 
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Among 31 patients who were urine culture positive on day 4, 28 were 
asymptomatic and 3 patients presented with symptoms like fever, abdominal 
pain, dysuria. Among 45 patients who were urine culture positive at the end 
of eight day 39 were asymptomatic and 6 presented with symptoms. 
Table X – Symptomatology of urine culture positive patients 
 
 
Urine culture positivity 
 
 
Asymptomatic 
patients Number 
(%) 
 
 
Symptomatic 
patients Number 
(%) 
 
On day 4 of catheterization     
(Total = 31) 
 
 
28 (91%) 
 
3 (9%) 
 
At the end of the eight day of 
catheterization (Total = 45) 
 
 
39 (87%) 
 
6 (13%) 
 
In our study, there were 14 diabetes mellitus patients based on history 
and fasting blood glucose level of more than 126 milligram per deciliter and 
postprandial blood glucose level of more than 200 milligram per deciliter. 
Out of these 14 diabetic patients, 8 were urine culture positive for 
microorganisms and 6 were urine culture negative. Out of the remaining 96 
non diabetic patients, 37 were urine culture positive for microorganisms and 
59 were urine culture negative. 
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Risk of catheter associated urinary tract infection among diabetics in 
our study was 57%. 
Risk of catheter associated urinary tract infection among non diabetics 
in our study was 39%. 
Among the 110 patients 32 patients had ultrasonographic evidence of 
renal calculi but all of these patients were without any symptom suggestive 
of renal calculi like characteristic loin pain, oliguria and azotemia. Out of 
these 32 renal calculi patients, 18 were urine culture positive for 
microorganisms and 14 were urine culture negative. Out of the remaining 78 
patients without renal calculi, 27 were urine culture positive for 
microorganisms and 51 were urine culture negative 
Risk of catheter associated urinary tract infection among renal calculi 
patients in our study was 53%. 
Risk of catheter associated urinary tract infection among patients 
without renal calculi in our study was 34%. 
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DISCUSSION 
Urinary tract infection (UTI) is the most common nosocomial 
infection with catheterization constituting the most frequent cause. Eighty 
percent and in some studies all of nosocomial urinary tract infections were 
associated with Foley’s catheter. 
This study was undertaken to analyse the incidence, sex risk, 
microbiological pattern, drug sensitivity, symptomatology, the influence of 
the days of catheterization, the influence of the associated co-morbid 
conditions in producing urinary tract infections in patients catheterized in 
Government Stanley Hospital. 
In this study 110 patients of which 57 were males and 53 were 
females were included. The most common indication for which the bladder 
was catheterized was Cerebrovascular accidents followed by 
neurodegenerative disorders.  
Among the 110 patients, 31 patients were urine culture positive on 
day three of catheterization. It constituted 28% of urine culture positive 
cases. This was consistent with the studies done by Tambyah et al where it 
was 30% and Henry Alaveran et al where it was 26%. 
At the end of day eight there were 45 urine culture positive patients. It 
constituted 41% of the total 110 patients. There was an increase by 18% 
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from day 4 to day 8 of catheterization. This was consistent from the studies 
by Somwang et al and Henry Alaveran et al where the risk of infection 
increased by 3 to 5% for each day of catheterisation. 
Among the 31 urine culture positive patients on day 4, 14 were males 
constituting 45% and 17 were females constituting 55%. Among the 45 
urine culture positive patients at the end of day 8, 20 were males constituting 
44% and 25 were females constituting 56%. The incidence of urinary tract 
infection among males in our study was 32% and that in females was 52%. 
This was consistent with studies done by Somwang et al and Tambyah et al 
which showed that females have a higher risk for catheter associated urinary 
tract infection. 
In most of the studies  like Herbert et al, Tambyah et al the 
commonest organism producing catheter associated urinary tract infection 
was Escherichia coli followed by Klebsiella pneumoniae. The most common 
organism producing catheter associated urinary tract infection in our study 
was Klebsiella pneumoniae (33%) followed by Escherichia coli (29%) and 
Enterococci (11%). A similar result was obtained in studies done by M. 
Sharifi et al in Iran and Tangtrakul et al in Thailand which showed that 
Klebsiella pneumoniae was commoner than Escherichia coli in catheter 
associated urinary tract infection. 
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In our study, the common organisms like Klebsiella pneumoniae and 
Escherichia coli were resistant at a high percentage to the commonly used 
antibiotics like erythromycin (93 %) and cotrimoxazole (60%). This was 
consistent with the studies done by Gupta K et al and Talan DA et al where 
there was increased resistance to the commonly used antibiotics.   
In our study, amikacin was sensitive to greater percentage of 
Klebsiella pneumoniae (93%) and Escherichia coli (100%). This was 
consistent with the studies done by Stickler DJ et al and the details of 
bacteriological spectrum for amikacin in Katzung text book of 
Pharmacology. 
In our study 87% of the 45 urine culture positive patients were 
asymptomatic. This was consistent with study by Tambyah et al where more 
than 90% of catheter associated urinary tract infection patients were 
asymptomatic. 
In our study all the patients were put on antibiotics from day one of 
catheterization. But still the risk of urinary tract infection in catheterized 
patients was 41% which was consistent with studies where the risk of 
infection was around 30% without any prophylactic antibiotics. This shows 
that there is no role for prophylactic antibiotics in catheter associated urinary 
tract infection. This was consistent with studies done by Warren JW et al 
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and Tambyah et al which showed that there was no role for prophylactic 
antibiotics in catheter associated urinary tract infection 
In our study the risk of catheter associated urinary tract infection in 
diabetes mellitus patients (57%) were more than the non diabetic patients 
(39%). Similarly the risk of catheter associated urinary tract infection in 
patients with renal calculi (53%) was more than the patients with out renal 
calculi (34%). This was consistent with studies done by Raz R et al and Ley 
WC et al where they showed increased risk of catheter associated urinary 
tract infection in diabetic and renal calculi patients.    
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CONCLUSION 
THE PRESENT STUDY INDICATES 
1. Urinary tract infection is common in catheterized patients. 
2. The risk of catheter associated urinary tract infection increases with 
the days of catheterization. 
3. Females were more at risk for catheter associated urinary tract 
infection than males. 
4. Klebsiella pneumoniae was commoner than Escherichia coli in 
producing catheter associated urinary tract infection in this study. 
5. There was increased resistance of catheter associated urinary tract 
infections to the commonly used antibiotics. 
6. Amikacin was sensitive to most of the catheter associated urinary 
tract infections. 
7. Most of the catheter associated urinary tract infection patients were 
asymptomatic. 
8. There was no role for prophylactic antibiotics in preventing catheter 
associated urinary tract infections. 
9. Patients with risk factors like diabetes mellitus and renal calculi were 
more at risk for catheter associated urinary tract infections. 
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PROFORMA 
Name    Age    Sex  
Complaints    Yes    No 
Fever 
Dysuria 
Loin pain 
Comorbid conditions  Yes    No 
Diabetes mellitus 
Renal calculi 
Renal failure 
Others 
Diagnosis for which admitted 
 
 
Current antibiotics (if any) 
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Investigations 
Blood      Others 
Total count      Chest X ray 
Differential count     Abdominal X ray 
ESR       Electrocardiogram    
Haemoglobin     Ultrasonogram abdomen 
Sugar 
Urea 
Creatinine  
Urine   Albumin  Sugar  Deposits 
Urine culture and sensitivity 
Organism grown 
Sensitive  
Resistant  
 
 
 
 
 
 
 
 
 
 
 
 
 
                
SEX DISTRIBUTION IN THE STUDY
MALE
52%
FEMALE
48%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SEX WISE RISK FOR URINE CULTURE POSITIVITY
25%
35%32%
52%
0%
10%
20%
30%
40%
50%
60%
FOURTH DAY EIGHTH DAY
DAYS OF CATHETERISATION
R
IS
K
 P
ER
C
E
N
TA
G
E
MALE
FEMALE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
URINE CULTURE RESULTS 
 
 
ON DAY FOUR OF CATHETERISATION
URINE 
CULTURE 
NEGATIVE
72%
URINE CULTURE 
POSITIVE
28%
 
 
 
 
 
                  
 
 
 
 
 
 
 
 
 
 
 
URINE CULTURE RESULTS 
 
 
 
 
             
ON DAY EIGHT OF 
CATHETERISATION 
URINE 
CULTURE 
NEGATIVE
59%
URINE 
CULTURE 
POSITIVE
41%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORGANISMS GROWN IN URINE CULTURE 
 
 
 
 
 DAY FOUR OF CATHETERISATION
36%
29%
13%
10%
6%
6%
Klebsiella pnemoniae
Escherichia coli
Enterococci
Pseudomonas
Staphylococcus aureus
Coagulase negative
staphylococci
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORGANISM GROWN IN URINE CULTURE 
 
 
 
DAY EIGHT OF CATHETERISATION
34%
29%
11%
9%
9%
7% 1%
Klebsiella pneumoniae
Escherichia coli
Enterococci
Pseudomonas
Staphylococcus aureus
Coagulase negative
staphylococci
Candida
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DRUG RESISTANCE PATTERN
7%
40%
53%
60%
60%
93%
60%
0%
15%
15%
23%
31%
39%
54%
0% 20% 40% 60% 80% 100%
Amikacin
Gentamicin
Ciprofloxacin
Norfloxacin
Cefataxim
Erythromycin
Cotrimaxazole
Escherichia coli
Klebsiella
pnemoniae
 
 
 
 
 
 
 
 
 
 
 
SYMPTOM PROFILE 
 
 
 
DAY EIGHT OF CATHETERISATION
SYMPTOMATIC
13%
ASYMPTOMATIC
87%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
